These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. A UK consensus on the management of the bladder in multiple sclerosis. Fowler CJ; Panicker JN; Drake M; Harris C; Harrison SC; Kirby M; Lucas M; Macleod N; Mangnall J; North A; Porter B; Reid S; Russell N; Watkiss K; Wells M J Neurol Neurosurg Psychiatry; 2009 May; 80(5):470-7. PubMed ID: 19372287 [TBL] [Abstract][Full Text] [Related]
8. Antimuscarinics for the treatment of overactive bladder: current options and emerging therapies. Hegde SS; Mammen M; Jasper JR Curr Opin Investig Drugs; 2004 Jan; 5(1):40-9. PubMed ID: 14983972 [TBL] [Abstract][Full Text] [Related]
9. Tolterodine once-daily in treatment of the overactive bladder. Peters KM; Huang RR Urology; 2001 Nov; 58(5):829-32. PubMed ID: 11711378 [No Abstract] [Full Text] [Related]
10. The pharmacotherapy of overactive bladder. Athanasopoulos A Expert Opin Pharmacother; 2011 May; 12(7):1003-5. PubMed ID: 21291348 [TBL] [Abstract][Full Text] [Related]
12. Factors involved in the success of antimuscarinic treatment. Abrams P; Larsson G; Chapple C; Wein AJ BJU Int; 1999 Mar; 83 Suppl 2():42-7. PubMed ID: 10210604 [No Abstract] [Full Text] [Related]
13. [Conservative treatment of functional disorders of the lower urinary tract]. Frohneberg D; Thüroff JW; Müller SC; Petri E Gynakologe; 1983 Dec; 16(4):206-13. PubMed ID: 6363223 [No Abstract] [Full Text] [Related]
14. The non-neurogenic neurogenic bladder. Allen TD J Urol; 1977 Feb; 117(2):232-8. PubMed ID: 833977 [TBL] [Abstract][Full Text] [Related]
15. Pharmacologic perspective on the physiology of the lower urinary tract. Andersson KE; Hedlund P Urology; 2002 Nov; 60(5 Suppl 1):13-20; discussion 20-1. PubMed ID: 12493344 [TBL] [Abstract][Full Text] [Related]
16. [Efficacy and safety of tamsulosin in women with bladder outlet obstruction]. Maksimov VA; Khodyreva LA; Dudareva AA; Aĭsina ÉF Urologiia; 2012; (5):115-6, 118-20. PubMed ID: 23342629 [No Abstract] [Full Text] [Related]
17. Detrol LA and Diropan XL for overactive bladder. Med Lett Drugs Ther; 2001 Apr; 43(1101):28. PubMed ID: 11283473 [No Abstract] [Full Text] [Related]
18. Drug treatment of overactive bladder: efficacy, cost and quality-of-life considerations. Hashim H; Abrams P Drugs; 2004; 64(15):1643-56. PubMed ID: 15257626 [TBL] [Abstract][Full Text] [Related]
19. [Bladder storage and voiding dysfunctions : Side effects of drug therapy]. Wolfesberger J; Falkensammer CE; Madersbacher S Urologe A; 2017 Apr; 56(4):456-464. PubMed ID: 28233038 [TBL] [Abstract][Full Text] [Related]